Revotaz 1.125 mg Injection 1's
₹98.1*
MRP ₹111.5
12% off
₹94.5*
MRP ₹111.5
15% CB
₹17 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Revotaz 1.125 mg Injection 1's belongs to the 'Antibiotics' class of drugs, primarily used to treat bacterial infections. It is used to treat various hospital-acquired and ventilator-associated pneumonia, urinary tract infections, intra-abdominal infections, skin and soft tissue infections (like diabetic foot infections) and uterine infections. Bacterial infection occurs when harmful bacteria grow in the body and causes illness. It can infect any part of the body and multiply very quickly.
Revotaz 1.125 mg Injection 1's contains two medicines, namely: Piperacillin (Penicillin antibiotic) and Tazobactam (beta-lactamase inhibitor). Piperacillin belongs to the class of 'Penicillin antibiotics.' It has bactericidal (ability to kill bacteria) activity against gram-positive and gram-negative aerobic (requires oxygen to survive) and anaerobic (survives with little or no oxygen) bacteria. Piperacillin acts by binding to the penicillin-binding proteins (PBPs) inside the bacterial cell wall and inhibits its cell wall synthesis. Tazobactam is a beta-lactamase inhibitor. Beta-lactamases are the enzymes produced by bacteria to gain multi-resistance to β-lactam antibiotics, such as penicillins and cephalosporins. Tazobactam prevents the breakdown of other antibiotics by beta-lactamase enzyme-producing organisms. In Revotaz 1.125 mg Injection 1's, Tazobactam works by preventing bacteria from destroying Piperacillin.
Revotaz 1.125 mg Injection 1's will be administered by a healthcare professional. Like all medicines, Revotaz 1.125 mg Injection 1's also causes side effects, although not everybody gets them. Common side effects of Revotaz 1.125 mg Injection 1's include nausea, constipation, diarrhoea, headache, and trouble sleeping. If any of these effects persist or worsen, seek medical advice promptly.
Brief your medical history to the doctor if you have any allergic reactions to antibiotics. Please inform your doctor if you have any liver, kidney diseases, bleeding disorders, and fits before using Revotaz 1.125 mg Injection 1's. Do not use Revotaz 1.125 mg Injection 1's while having vaccinations with live bacterial vaccines (typhoid vaccine) since Revotaz 1.125 mg Injection 1's may affect vaccines' activity. Revotaz 1.125 mg Injection 1's should be used during pregnancy only if the doctor advises you. It is also excreted into breast milk in small amounts. Hence, it is recommended to consult your doctor if you are pregnant or breastfeeding before taking Revotaz 1.125 mg Injection 1's.
Revotaz 1.125 mg Injection 1's contains two medicines, namely: Piperacillin and Tazobactam. Piperacillin is a Penicillin antibiotic. It acts by binding to the penicillin-binding proteins (PBPs) inside the bacterial cell wall and inhibits its cell wall synthesis. Tazobactam is a beta-lactamase inhibitor that prevents the breakdown of other antibiotics by beta-lactamase enzyme-producing organisms. In Revotaz 1.125 mg Injection 1's, Tazobactam works by preventing bacteria from destroying Piperacillin. Thus, Revotaz 1.125 mg Injection 1's helps treat various bacterial infections of the stomach, lungs, skin and uterus.
If you have a history of any cystic fibrosis (damaged lungs and digestive system), kidney disease, fits, colitis (inflammation of the colon), bleeding disorders, or heart or liver diseases, please inform your doctor before starting Revotaz 1.125 mg Injection 1's. Please seek medical advice if you are pregnant or breastfeeding before taking Revotaz 1.125 mg Injection 1's. Patients aged above 65 years are not at an increased risk of having side effects. However, the dosage should be adjusted if the patient has a history of renal impairment. Safety and efficacy of Revotaz 1.125 mg Injection 1's in children less than two months of age have not been established.
Drug-Drug Interaction: Revotaz 1.125 mg Injection 1's may interact with anticoagulants (heparin), anti-cancer drugs (methotrexate), antibiotics (tobramycin, vancomycin), gout medicines (probenecid), and anaesthetic drugs (vecuronium).
Drug-Food Interaction: Avoid alcohol consumption while taking Revotaz 1.125 mg Injection 1's to prevent unpleasant side-effects, such as nausea and vomiting.
Drug-Disease Interaction: Before taking Revotaz 1.125 mg Injection 1's, let your doctor know if you have cystic fibrosis, kidney disease, fits, colitis, bleeding disorders, heart or liver diseases, and are undergoing dialysis treatment.
Renal, hepatic, and blood function tests are advised during prolonged therapy to rule out any toxicity caused due to overdose of Revotaz 1.125 mg Injection 1's.
Clostridium difficile-associated diarrhoea (CDAD) is reported during the usage of antibiotics like Revotaz 1.125 mg Injection 1's. Please see your doctor if you experience prolonged diarrhoea.
Penicillin antibiotics are easily removed during dialysis; hence let your doctor know if you are undergoing dialysis treatment so that the dose can be scheduled after the dialysis.
Revotaz 1.125 mg Injection 1's may also affect urine glucose tests; hence inform your doctor beforehand if you are using Revotaz 1.125 mg Injection 1's.
Bacterial infection occurs when harmful bacteria grow in the body and causes illness. It can infect any part of the body and multiply very quickly. Bacteria occur in three basic shapes: spherical, rod and spiral-shaped. Bacteria may be gram-positive (have thick cell wall) or gram-negative (do not have a cell wall). Some common symptoms of a bacterial infection include cough, fever and tiredness.
Hospital-acquired pneumonia/ nosocomial pneumonia: It is a lower respiratory infection of the lungs that occurs during a hospital stay.
Ventilator-associated pneumonia: A lung infection occurs in people who are on mechanical ventilation breathing machines in hospitals.
Alcohol
Caution
Avoid alcohol consumption while taking Revotaz 1.125 mg Injection 1's to prevent unpleasant side-effects, such as nausea and vomiting.
Pregnancy
Caution
Revotaz 1.125 mg Injection 1's should be used with caution during pregnancy since it crosses the placenta in humans. Please consult your doctor before taking Revotaz 1.125 mg Injection 1's if you are pregnant or planning to conceive.
Breast Feeding
Caution
There is limited data on how Revotaz 1.125 mg Injection 1's affects breastfed infants. Revotaz 1.125 mg Injection 1's is excreted into breast milk. Please consult your doctor before taking Revotaz 1.125 mg Injection 1's if you are breastfeeding.
Driving
Caution
It is unknown whether Revotaz 1.125 mg Injection 1's affects your ability to drive and operating machinery. Drive only if you are physically stable and mentally focussed. If you experience dizziness or fatigue after taking Revotaz 1.125 mg Injection 1's, do not drive or operate any machinery.
Liver
Caution
Let your doctor know if you have any history of liver diseases before taking Revotaz 1.125 mg Injection 1's. Your doctor will prescribe Revotaz 1.125 mg Injection 1's only if the benefits outweigh the risk.
Kidney
Caution
Penicillin antibiotics are easily removed by dialysis. Beta-lactam antibiotics like Tazobactam should be cautiously administered in patients with renal impairment. Prolonged use of Revotaz 1.125 mg Injection 1's may cause nephrotoxicity and alterations in renal function, hence please let your doctor know if you have any history of kidney diseases before taking Revotaz 1.125 mg Injection 1's. Your doctor will prescribe Revotaz 1.125 mg Injection 1's only if the benefits outweigh the risk.
Children
Caution
Safety and efficacy of Revotaz 1.125 mg Injection 1's in children less than two months of age have not been established.
Country of origin
Manufacturer/Marketer address
Product Substitutes